World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.

Traditional & Kampo Medicine is a distinguished journal published by Wiley, focusing on the rich traditions and scientific advancements in complementary and alternative medicine, particularly within the realms of Traditional Chinese medicine and Kampo. With an E-ISSN of 2053-4515, this journal serves as a pivotal platform for researchers, professionals, and students interested in exploring the integration and evidence-based application of traditional healing practices in contemporary medical contexts. Since its inception in 2014 and projected until 2024, it has carved out a notable place in academic contributions, being ranked in the 3rd quartile for Complementary and Alternative Medicine and the 4th quartile for Pharmacology (Medical) as of 2023. While the access options are not explicitly stated, the journal fosters scholarly debate and disseminates innovative findings that underscore the importance of traditional healing methodologies within modern healthcare paradigms. By bridging ancient wisdom and scientific inquiry, Traditional & Kampo Medicine plays a crucial role in advancing the understanding and application of holistic health approaches.

Recent Patents on Anti-Cancer Drug Discovery, published by Bentham Science Publishers Ltd, is an esteemed peer-reviewed journal specializing in the innovative intersection of pharmaceutical science and oncology. With an ISSN of 1574-8928 and an E-ISSN of 2212-3970, this journal aims to provide a comprehensive platform for the dissemination of recent developments in anti-cancer drug discovery, addressing critical issues and breakthroughs that influence cancer research and treatment. The journal spans from 2006 to 2024 and is indexed in several prestigious databases, showcasing its relevance with a Q3 ranking in key categories such as Cancer Research and Drug Discovery as of 2023. Its status of being open access reflects a commitment to making valuable scientific findings widely available, promoting collaboration and advancement in the field. With a dedicated focus on advancing knowledge in cancer therapeutics, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to contribute to the fight against cancer.

MOLECULAR CANCER THERAPEUTICS, published by the American Association for Cancer Research, is a premier journal dedicated to advancing the field of cancer research and therapy since 2001. With a notable impact factor reflecting its high-quality content, this journal stands out in the Q1 category for both Cancer Research and Oncology as of 2023. Researchers, clinicians, and students interested in innovative treatment strategies and molecular mechanisms can find valuable insights within its pages, bolstered by a rigorous peer-review process and a global perspective on cancer therapeutic developments. Although the journal operates under a subscription model, it provides comprehensive access to cutting-edge studies and reviews that drive forward the understanding of cancer biology and treatment modalities. The journal's impressive Scopus rankings further validate its influence within both oncology and the broader cancer research community, making it an indispensable resource for anyone committed to combating cancer through science.

Oncologie is a distinguished academic journal published by WALTER DE GRUYTER GMBH, focusing on the dynamic and vital field of oncology. Established in 1999 and continuously published until 2024, this journal provides a platform for high-quality research and advancements in cancer treatment, prevention, and diagnosis. With an ISSN of 1292-3818 and an E-ISSN of 1765-2839, it is indexed in various databases, contributing to its growing visibility. Although categorized in the Q3 quartile for oncology research as of 2023, Oncologie offers essential insights and fosters scholarly dialogue among researchers, professionals, and students interested in oncology. Its unique contributions aim to bridge the gap between theoretical frameworks and clinical applications, making it a valuable resource for those seeking to advance their knowledge and expertise in cancer research.

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, published by Mary Ann Liebert, Inc., stands at the forefront of research in the field of Complementary and Alternative Medicine. With an ISSN of 1075-5535 and an E-ISSN of 1557-7708, this journal has been a pivotal source of scholarly articles since its inception in 1995, although its coverage in Scopus was discontinued in 2021. Renowned for its rigorous peer-review process and high-quality contributions, the journal ranks 23rd out of 93 in the Medicine-Complementary and Alternative Medicine category, firmly positioning it in the 75th percentile. Aimed at researchers, professionals, and students, the journal provides accessible insights into the interdisciplinary studies of alternative therapies and holistic health practices. With evolving open access options, it continues to disseminate crucial knowledge that can shape future therapeutic developments and influence healthcare practices. Explore the impactful content that can support and expand your understanding of complementary medicine at JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE.

INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.

COMPLEMENTARY THERAPIES IN MEDICINE, published by Churchill Livingstone, is a premier Open Access journal that has been at the forefront of advancing knowledge in the fields of complementary and alternative medicine since its inception in 1993. With a strong impact in health professions, nursing, and complementary therapies, this journal holds a prestigious spot in the top quartile rankings for 2023, including Q1 classifications in Advanced and Specialized Nursing, Complementary and Alternative Medicine, and Complementary and Manual Therapy. Its Scopus rankings further attest to its significance, being ranked #1 in Complementary and Manual Therapy with an impressive 97th percentile. The journal's commitment to accessibility is underscored by its Open Access policy since 2021, ensuring that researchers, professionals, and students have unrestricted access to high-quality research that informs practice and policy. With a focus on evidence-based approaches, the journal serves as an essential resource for those looking to integrate complementary therapies into holistic healthcare strategies.

Current Cancer Therapy Reviews, an esteemed journal published by Bentham Science Publishers Ltd, serves as a critical resource in the fields of cancer research, molecular medicine, and oncology. With an ISSN of 1573-3947 and an E-ISSN of 1875-6301, this journal provides a platform for the rapid dissemination of reviews that articulate the latest advancements and therapeutic strategies in cancer treatment. Although it currently holds a Q4 classification in its respective categories, the journal's commitment to quality scholarship is evident in its engagement with an expansive range of topics impacting cancer care. Operating from the United Arab Emirates since its inception in 2006, it is an essential tool for researchers, clinicians, and students aiming to stay abreast of the evolving landscape of cancer therapy. The journal emphasizes open access to knowledge, fostering a collaborative environment for innovative research. For those looking to deepen their understanding of contemporary cancer therapies, Current Cancer Therapy Reviews is a valuable addition to their academic resources.

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.